{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:17:26Z","timestamp":1789773446065,"version":"4.0.1"},"reference-count":28,"publisher":"American Diabetes Association","issue":"4","license":[{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11,1]]},"abstract":"<jats:p>The landscape for managing type 1 diabetes during pregnancy has been transformed by increasing use of continuous glucose monitoring (CGM). Women are aiming for pregnancy-specific glucose targets or 70% time in range for pregnancy (TIRp; 63\u2013140 mg\/dL) as soon as possible, knowing that every extra 5% TIRp has benefits for reducing the risks of complications in their babies. Ongoing monitoring of maternal A1C (at pregnancy confirmation and at 20, 28, and 36 weeks\u2019 gestation) remains useful. Intensification of glycemic management and instruction in using CGM (if not already used) is recommended for individuals with an A1C &amp;gt;6.0% after 20 weeks. A better understanding of CGM-documented glycemic changes throughout pregnancy is needed to inform future management of gestational diabetes and pregnancy in people with type 2 diabetes. Research regarding overcoming barriers to CGM use and optimal TIRp targets for pregnant individuals with type 2 diabetes from diverse racial\/ethnic groups is urgently needed.<\/jats:p>","DOI":"10.2337\/dsi23-0004","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T20:04:28Z","timestamp":1700078668000},"page":"315-319","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":8,"title":["Roadmap to the Effective Use of Continuous Glucose Monitoring in Pregnancy"],"prefix":"10.2337","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6876-8727","authenticated-orcid":false,"given":"Helen R.","family":"Murphy","sequence":"first","affiliation":[{"name":"Norwich Medical School, University of East Anglia, Norwich, U.K., and Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2023,11,15]]},"reference":[{"key":"2023111520040117600_B1","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0140-6736(17)32400-5","article-title":"Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial","volume":"390","author":"Feig","year":"2017","journal-title":"Lancet"},{"key":"2023111520040117600_B2","doi-asserted-by":"crossref","first-page":"E627","DOI":"10.9778\/cmajo.20200128","article-title":"The cost implications of continuous glucose monitoring in pregnant women with type 1 diabetes in 3 Canadian provinces: a posthoc cost analysis of the CONCEPTT trial","volume":"9","author":"Ahmed","year":"2021","journal-title":"CMAJ Open"},{"key":"2023111520040117600_B3","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1111\/dme.14046","article-title":"Modelling potential cost savings from use of real-time continuous glucose monitoring in pregnant women with type 1 diabetes","volume":"36","author":"Murphy","year":"2019","journal-title":"Diabet Med"},{"key":"2023111520040117600_B4","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1089\/dia.2020.0223","article-title":"Managing diabetes in pregnancy before, during, and after COVID-19","volume":"22","author":"Murphy","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"2023111520040117600_B5","doi-asserted-by":"crossref","first-page":"o875","DOI":"10.1136\/bmj.o875","article-title":"Ockenden report: the refusal of our healthcare service to take patient experience seriously","volume":"377","author":"Sibley","year":"2022","journal-title":"BMJ"},{"key":"2023111520040117600_B6","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2337\/cd17-0094","article-title":"Does time-in-range matter? Perspectives from people with diabetes on the success of current therapies and the drivers of improved outcomes","volume":"36","author":"Runge","year":"2018","journal-title":"Clin Diabetes"},{"key":"2023111520040117600_B7","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12884-022-04543-z","article-title":"AiDAPT: automated insulin delivery amongst pregnant women with type 1 diabetes: a multicentre randomized controlled trial - study protocol","volume":"22","author":"Lee","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"key":"2023111520040117600_B8","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the International Consensus on Time in Range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"2023111520040117600_B9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S2213-8587(20)30406-X","article-title":"Characteristics and outcomes of pregnant women with type 1 or type 2 diabetes: a 5-year national population-based cohort study","volume":"9","author":"Murphy","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2023111520040117600_B10","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.2337\/dc22-0078","article-title":"Continuous glucose monitoring metrics and birth weight: informing management of type 1 diabetes throughout pregnancy","volume":"45","author":"Scott","year":"2022","journal-title":"Diabetes Care"},{"key":"2023111520040117600_B11","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00125-019-4904-3","article-title":"Continuous glucose monitoring targets in type 1 diabetes pregnancy: every 5% time in range matters","volume":"62","author":"Murphy","year":"2019","journal-title":"Diabetologia"},{"key":"2023111520040117600_B12","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00125-019-4850-0","article-title":"Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnancies","volume":"62","author":"Kristensen","year":"2019","journal-title":"Diabetologia"},{"key":"2023111520040117600_B13","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2337\/dc20-2360","article-title":"Novel biochemical markers of glycemia to predict pregnancy outcomes in women with type 1 diabetes","volume":"44","author":"Meek","year":"2021","journal-title":"Diabetes Care"},{"key":"2023111520040117600_B14","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1007\/s00125-020-05174-9","article-title":"Adults with early-onset type 2 diabetes (aged 18\u201339\u00a0years) are severely underrepresented in diabetes clinical research trials","volume":"63","author":"Sargeant","year":"2020","journal-title":"Diabetologia"},{"key":"2023111520040117600_B15","doi-asserted-by":"crossref","first-page":"e14506","DOI":"10.1111\/dme.14506","article-title":"Prevalence of anxiety and depression symptoms in pregnant women with type 2 diabetes and the impact on glycaemic control","volume":"38","author":"\u00c1sbj\u00f6rnsd\u00f3ttir","year":"2021","journal-title":"Diabet Med"},{"key":"2023111520040117600_B16","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.2337\/dc07-0500","article-title":"Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy","volume":"30","author":"Murphy","year":"2007","journal-title":"Diabetes Care"},{"key":"2023111520040117600_B17","first-page":"CD009613","article-title":"Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes","volume":"5","author":"Jones","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2023111520040117600_B18","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.2337\/dc12-2360","article-title":"The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial","volume":"36","author":"Secher","year":"2013","journal-title":"Diabetes Care"},{"key":"2023111520040117600_B19","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/dom.13310","article-title":"Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial","volume":"20","author":"Voormolen","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"2023111520040117600_B20","doi-asserted-by":"crossref","first-page":"a1680","DOI":"10.1136\/bmj.a1680","article-title":"Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial","volume":"337","author":"Murphy","year":"2008","journal-title":"BMJ"},{"key":"2023111520040117600_B21","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.2337\/dci21-0059","article-title":"Pregnancy outcomes of young women with type 2 diabetes: poor care and inadequate attention to glycemia","volume":"45","author":"Murphy","year":"2022","journal-title":"Diabetes Care"},{"key":"2023111520040117600_B22","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.2337\/dc11-0723","article-title":"Continuous glucose profiles in obese and normal-weight pregnant women on a controlled diet: metabolic determinants of fetal growth","volume":"34","author":"Harmon","year":"2011","journal-title":"Diabetes Care"},{"key":"2023111520040117600_B23","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.2337\/dc11-0241","article-title":"Patterns of glycemia in normal pregnancy: should the current therapeutic targets be challenged?","volume":"34","author":"Hernandez","year":"2011","journal-title":"Diabetes Care"},{"key":"2023111520040117600_B24","doi-asserted-by":"crossref","first-page":"1174239","DOI":"10.3389\/fendo.2023.1174239","article-title":"Effect of continuous glucose monitoring compared with self-monitoring of blood glucose in gestational diabetes patients with HbA1c&lt;6%: a randomized controlled trial","volume":"14","author":"Lai","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2023111520040117600_B25","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1056\/NEJMoa2214956","article-title":"Treatment of gestational diabetes mellitus diagnosed early in pregnancy","volume":"388","author":"Simmons","year":"2023","journal-title":"N Engl J Med"},{"key":"2023111520040117600_B26","doi-asserted-by":"crossref","first-page":"982","DOI":"10.2337\/dc16-0160","article-title":"Accelerated fetal growth prior to diagnosis of gestational diabetes mellitus: a prospective cohort study of nulliparous women","volume":"39","author":"Sovio","year":"2016","journal-title":"Diabetes Care"},{"key":"2023111520040117600_B27","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/0002-9378(91)90418-Q","article-title":"The role of repeat glucose tolerance tests in the diagnosis of gestational diabetes","volume":"165","author":"Neiger","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"2023111520040117600_B28","doi-asserted-by":"crossref","first-page":"e14380","DOI":"10.1111\/dme.14380","article-title":"Approaches to screening for hyperglycaemia in pregnant women during and after the COVID-19 pandemic","volume":"38","author":"Meek","year":"2021","journal-title":"Diabet Med"}],"container-title":["Diabetes Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/spectrum\/article-pdf\/36\/4\/315\/737917\/diaspectdsi230004.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/spectrum\/article-pdf\/36\/4\/315\/737917\/diaspectdsi230004.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T20:04:37Z","timestamp":1700078677000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/spectrum\/article\/36\/4\/315\/153826\/Roadmap-to-the-Effective-Use-of-Continuous-Glucose"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,11,15]]},"published-print":{"date-parts":[[2023,11,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dsi23-0004","relation":{},"ISSN":["1040-9165","1944-7353"],"issn-type":[{"value":"1040-9165","type":"print"},{"value":"1944-7353","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,1]]}}}